ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Hamburg Confirmed As FDA Commissioner

May 22, 2009

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991